{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:05:39Z","timestamp":1787655939590,"version":"build-2736575974"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jac\/dkx140","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T11:23:19Z","timestamp":1492687399000},"page":"2342-2350","source":"Crossref","is-referenced-by-count":33,"title":["Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies"],"prefix":"10.1093","volume":"72","author":[{"given":"Pier Giorgio","family":"Cojutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Candoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Ramos-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Zannier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"key\n\t\t\t\t20171012141818_dkx140-B1","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1086\/427331","article-title":"Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B3","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ijantimicag.2008.06.017","article-title":"Bloodstream infections in cancer patients with febrile neutropenia","volume":"32","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B5","doi-asserted-by":"crossref","first-page":"O7","DOI":"10.1111\/1469-0691.12294","article-title":"An 8-year survey of strains identified in blood cultures in a clinical haematology unit","volume":"20","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/00365540903496569","article-title":"Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution","volume":"42","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2005.05.007","article-title":"The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients","volume":"10","year":"2006","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bcp.12310","article-title":"The prevention and management of infections due to multidrug resistant organisms in haematology patients","volume":"79","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00003495-200464040-00009","article-title":"Daptomycin","volume":"64","year":"2004","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B11","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/AAC.00227-16","article-title":"Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1177\/1060028013508272","article-title":"Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2\u2009\u03bcg\/mL","volume":"47","year":"2013","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B13","first-page":"1600","article-title":"Evaluation of daptomycin exposure and efficacy and safety endpoints to support risk-versus-benefit considerations","volume":"60","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003088-200443060-00004","article-title":"Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages","volume":"43","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B15","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/AAC.49.8.3550-3553.2005","article-title":"Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B16","doi-asserted-by":"crossref","first-page":"772.","DOI":"10.1016\/j.ejim.2013.08.004","article-title":"Clinical characteristics and prognostic significance of serum albumin changes in an internal medicine ward","volume":"24","year":"2013","journal-title":"Eur J Intern Med"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1071::AID-CNCR9>3.0.CO;2-H","article-title":"Nutrition and acute leukemia in adults: relation between nutritional status and infectious complications during remission induction","volume":"82","year":"1998","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejim.2007.04.029","article-title":"Prevalence and significance of hypoalbuminemia in an internal medicine department","volume":"19","year":"2008","journal-title":"Eur J Intern Med"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2011.92","article-title":"Implications of augmented renal clearance in critically ill patients","volume":"7","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/AAC.00891-08","article-title":"Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B21","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/jac\/dkv123","article-title":"Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B22","first-page":"e37.","article-title":"TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient","volume":"45","year":"2011","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jchromb.2008.09.019","article-title":"Validated high performance liquid chromatography-UV detection method for the determination of daptomycin in human plasma","volume":"875","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/j.ajkd.2012.08.001","article-title":"GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly","volume":"60","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","year":"1976","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","year":"2012","journal-title":"Ther Drug Monit"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B27","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/652767","article-title":"Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B28","volume-title":"Clinical Breakpoints","author":"EUCAST","year":"2015"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B29","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1128\/AAC.02597-15","article-title":"Pharmacokinetic variability of daptomycin during prolonged therapy for bone and joint infections","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B30","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/cit582","article-title":"Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B31","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.48.8.2799-2807.2004","article-title":"Population pharmacokinetics of daptomycin","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijantimicag.2013.06.006","article-title":"Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections","volume":"42","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.00943-08","article-title":"Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/44.2.235","article-title":"Population pharmacokinetics of amikacin in patients with haematological malignancies","volume":"44","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/AAC.34.5.702","article-title":"Increased aminoglycoside dosage requirements in hematologic malignancy","volume":"34","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/AAC.35.7.1501","article-title":"Gentamicin pharmacokinetics in patients with malignancies","volume":"35","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/AAC.35.5.944","article-title":"Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy","volume":"35","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF02310354","article-title":"Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia","volume":"14","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B39","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1128\/AAC.49.12.4934-4941.2005","article-title":"Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B40","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","article-title":"Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability","volume":"44","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijantimicag.2010.02.013","article-title":"Augmented renal clearance in the Intensive Care Unit: an illustrative case series","volume":"35","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijantimicag.2016.04.022","article-title":"Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis","volume":"48","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/600039","article-title":"Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijantimicag.2011.07.003","article-title":"Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital","volume":"38","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","article-title":"High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study","volume":"31","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20171012141818_dkx140-B48","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.00247-06","article-title":"Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/8\/2342\/18801383\/dkx140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T11:14:40Z","timestamp":1569064480000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/72\/8\/2342\/3859998\/Population-pharmacokinetics-and-dosing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx140","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,6,1]]}}}